
Overview
Life science REIT reported Q4 2025 net loss per share of $6.35
FFO per share, as adjusted, was $2.16 for Q4 2025
Company reduced quarterly dividend by 45% to $0.72 per share
Outlook
Alexandria projects 2026 adj FFO per share between $6.25 and $6.55
Company targets 2026 occupancy in North America between 87.7% and 89.3%
Alexandria expects 2026 rental rate changes from down 2.0% to up 6.0%
Result Drivers
TENANT COLLECTIONS - Alexandria reported strong tenant collections with 99.9% of rents and receivables collected as of January 26, 2026
COST REDUCTIONS - Co achieved a 30% reduction in general and administrative expenses in 2025, primarily from cost-control initiatives
CAPITAL RECYCLING - Alexandria completed $1.47 bln of dispositions in 4Q25, exceeding its 2025 guidance midpoint
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 EPS |
| -$6.35 |
|
Q4 Adjusted FFO Per Share |
| $2.16 |
|
Q4 Dividend |
| $0.72 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the commercial reits peer group is "buy."
Wall Street's median 12-month price target for Alexandria Real Estate Equities Inc is $60.00, about 0.5% above its January 23 closing price of $59.69
Press Release: ID:nPn8GzQC9a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.